Archives des Clostridium difficile infection

What are the factors that predict complications associated with Clostridioides difficile infection and what can be done in clinical practice?

21 Nov 2022

by Andreu Prados

Clostridioides difficile infection is a common cause of diarrhea in both the hospital and community settings, with C. difficile recurrence one of the most challenging outcomes to address. This article focuses on the factors that predict long-term complications of C. difficile infection and what can be done in clinical practice to minimize them (Part 5).

November, Clostridioides difficile infection awareness month

11 Nov 2022

by Konstantina Zafeiropoulou

Just one month before friends and families gather around the Christmas table, November is here to bring awareness around Clostridioides difficile infection, and the importance of microbiota-derived treatments. With this post, all of us in GMFH aim to highlight the importance of protecting ourselves and families and stopping the spread of this potentially deadly infection.

Fecal transplants and defined commensal consortia: the pros and cons of restoring the gut microbiome in recurrent Clostridioides difficile infection

19 Sep 2022

by Andreu Prados

Correcting the altered gut microbiome is an important goal in Clostridioides difficile management, but the matter is not addressed by mainstream treatments with antibiotics. This article focuses on where fecal microbiota transplantation and investigational microbiota-based therapeutics stand for C. difficile infection (Part 3)

How can you accurately diagnose and manage Clostridioides difficile infection?

10 Jun 2022

by Andreu Prados

Clostridioides difficile infection is a common cause of diarrhea, not only in hospitals but also in outpatient settings. This article focuses on the diagnosis and treatment of C. difficile infection and includes an updated summary of literature on the latest guidelines (Part 2).

Clostridioides difficile infection remains an unfamiliar subject for clinicians

25 Feb 2022

by Andreu Prados

Clostridioides difficile infection is the most frequent cause of antibiotic-associated diarrhea in the hospital setting that has increased in severity. This article looks at the risk factors for developing C. difficile-associated disease, the spectrum of manifestations and the impact of the COVID-19 pandemic on the occurrence of C. difficile infection.

Gut microbiota signatures may predict how individuals respond to primary treatment for Clostridium difficile infection

28 Nov 2016

by Andreu Prados

A recent study, led by Dr. Purna C. Kashyap from the Division of Gastroenterology and Hepatology at Mayo Clinic in Rochester (USA), has found that gut microbiota signatures may allow identification of patients with Clostridium difficile infection who will respond to initial treatment.